welcome

TrialSpark, which wants to leverage its clinical trials management software into drug discovery, closed $156M Series C at a $1B+ valuation earlier this year (Emma Court/Bloomberg)

Emma Court / Bloomberg:
TrialSpark, which wants to leverage its clinical trials management software into drug discovery, closed $156M Series C at a $1B+ valuation earlier this year  —  - TrialSpark expands from clinical trials into developing drugs  — Company raised $156 million, is valued at more than $1 billion



from Techmeme https://ift.tt/3usrF0k

Share this:

Post a Comment

 
Copyright © TECH UPDATES. Designed by OddThemes & Best Wordpress Themes 2018